title: Erysipeloid rash: A rare adverse event induced by gemcitabine.
abstract: Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema.
authors.affiliation: Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Ruiz-Casado
authors.forename: David
authors.initials: D
authors.lastname: Gutiérrez
authors.forename: Ignacio
authors.initials: I
authors.lastname: Juez
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000328:Adult; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004887:Erysipeloid / Q000139:chemically induced* / Q000473:pathology; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D035583:Rare Diseases / Q000139:chemically induced* / Q000473:pathology; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D000093542:Gemcitabine